Cargando…
Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision‐making processes
To evaluate whether the addition of biomarkers to traditional clinicopathological parameters may help to increase the accurate prediction of prostate re‐biopsy outcome. A training cohort with 98 patients and a validation cohort with 72 patients were retrospectively recruited into our study. Immunohi...
Autores principales: | Long, Xingbo, Wu, Longxiang, Zeng, Xiting, Wu, Zhijian, Hu, Xiheng, Jiang, Huichuan, Lv, Zhengtong, Yang, Changzhao, Cai, Yi, Yang, Keda, Li, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571822/ https://www.ncbi.nlm.nih.gov/pubmed/32860339 http://dx.doi.org/10.1002/cam4.3419 |
Ejemplares similares
-
Evaluation of transrectal ultrasound-based dosimetry for brachytherapy of prostate cancer: a single-center experience
por: Yang, Changzhao, et al.
Publicado: (2020) -
Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
por: Alkema, Nicolette G., et al.
Publicado: (2022) -
Immunohistochemistry for Prostate Biopsy—Impact on Histological Prostate Cancer Diagnoses and Clinical Decision Making
por: Mandel, Philipp, et al.
Publicado: (2021) -
Identification of a Novel Glycolysis-Related Gene Signature Correlates With the Prognosis and Therapeutic Responses in Patients With Clear Cell Renal Cell Carcinoma
por: Lv, Zhengtong, et al.
Publicado: (2021) -
Role of Prostate-Specific Antigen Change Ratio at Initial Biopsy as a Novel Decision-Making Marker for Repeat Prostate Biopsy
por: Lee, Jung Gon, et al.
Publicado: (2012)